Table I.
Authors | Year | Patients, n | Follow-up, mo | AFE, ° | VAS pain score | ASES score | Constant score | SST score | Cx, % |
---|---|---|---|---|---|---|---|---|---|
Alentorn-Geli et al1 | 2017 | 31 | 28 | 109 | 1 | NA | NA | NA | 21 |
Black et al4 | 2015 | 16 | 59 | NA | 1.7 | 67 | NA | 5.3 | 56 |
Black et al5 | 2014 | 36 | 55 | NA | 1.4 | 70 | NA | 5.9 | 28 |
Boileau et al7 | 2013 | 37 | 34 | 111 | NA | NA | 47 | NA | 30 |
Castagna et al12 | 2013 | 36 | 32 | 120 | NA | NA | 48 | NA | 0 |
Chacon et al13 | 2009 | 25 | 30 | 82 | NA | 70 | NA | 4.5 | 16 |
Cox et al15 | 2019 | 73 | 68 | 75 | NA | 51 | NA | 3.5 | 19 |
Flury et al18 | 2011 | 21 | 46 | 97 | 3 | NA | 56 | NA | 43 |
Hernandez et al20 | 2017 | 70 | 36 | 112 | NA | 68 | NA | 7 | NA |
Holcomb et al22 | 2009 | 14 | 33 | 118 | NA | 70 | NA | 4.5 | 21 |
Holschen et al23 | 2017 | ||||||||
GHOA cohort | 23 | 24 | 126 | 1.5 | 59 | 67 | NA | 9 | |
Fracture cohort | 21 | 24 | 115 | 2.2 | 71 | 73 | NA | 24 | |
Kany et al26 | 2015 | 29 | 28 | 124 | 2 | NA | 60 | 8 | 0 |
Kelly et al27 | 2012 | 28 | 34 | 106 | NA | 72 | 49 | NA | 50 |
Melis et al31 | 2012 | 37 | 47 | 121 | NA | NA | 55 | NA | 30 |
Merolla et al32 | 2018 | 157 | 49 | NA | 2.2 | 60 | NA | 6 | NA |
Ortmaier et al35 | 2013 | 50 | 51 | 98 | 1 | NA | 49 | 5.6 | 24 |
Patel et al36 | 2012 | 28 | 41 | 108 | 2.6 | 66 | NA | 7.6 | 11 |
Sheth et al40 | 2019 | 110 | 57 | NA | 2.9 | 63 | NA | NA | 20 |
Shields and Wiater41 | 2019 | 35 | 50 | NA | 2.4 | 68 | NA | NA | 31 |
Stephens et al43 | 2016 | 58 | 24 | 97 | 3.5 | 53 | NA | 4.4 | 18 |
Stephens et al45 | 2015 | 16 | 36 | 100 | 2.6 | 67 | NA | 5.3 | 31 |
Valenti et al48 | 2014 | 30 | 36 | 108 | NA | NA | 52 | NA | 27 |
Wagner et al50 | 2015 | 143 | 37 | NA | NA | 66 | NA | 6 | 18 |
Wagner et al52 | 2017 | 39 | 36 | 121 | NA | 68 | NA | 6.8 | 15 |
Wagner et al51 | 2017 | 38 | 44 | 108 | NA | 61 | NA | 5 | 26 |
Walker et al53 | 2012 | 22 | 40 | 130 | NA | 68 | NA | 5 | 23 |
Weighted mean or total | NA | 1223 | NA | 106 ± 15 | 3 ± 2 | 63 ± 6 | 54 ± 8 | 5.7 ± 1.1 | 22 |
AFE, active forward elevation; VAS, visual analog scale; ASES, American Shoulder and Elbow Surgeons; SST, Simple Shoulder Test score; Cx, complications; NA, not available; GHOA, glenohumeral osteoarthritis.
Data are presented as mean values unless otherwise indicated.